Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)

v3.20.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Common Stock Subscribed But Not Issued [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Balances at December 31, 2019 at Dec. 31, 2018 $ 211,013 $ 169,123 $ 87,180,165 $ (25,575,808) $ (220,032) $ 61,764,461
Balance, shares at Dec. 31, 2018 211,013,043 97,136        
Sales of common stock $ 800 2,599,200 2,600,000
Sales of common stock, shares 799,995          
Issuance of subscribed shares $ 97 $ (169,123) 169,026
Balance, shares 97,136 (97,136)        
Stock grants    
MediTaurus acquisition $ 2,080,000 1,200,000 3,280,000
MediTaurus acquisition, shares 752,260        
Terrace investment $ 500 1,589,500 1,590,000
Terrace investment, shares 500,000        
Harvest payment $ 1,000 (1,000)
Harvest payment, shares 1,000,000        
Exercise of options $ 359   12,641     13,000
Exercise of options, shares 358,446          
Exercise of warrants $ 666 601,776 602,442
Exercise of warrants, shares 666,104        
Amortization of option and warrant issuances 2,458,941 2,458,941
Beneficial conversion feature on debentures payable 3,384,980 3,384,980
Conversion of debentures payable $ 1,156 2,626,601 2,627,754
Conversion of debentures payable, shares 1,156,379          
Conversion of promissory note      
Conversion of promissory notes, shares          
Extinguishment of promissory note      
Extinguishment of promissory note, shares          
Common stock issued to settle obligations      
Common stock issued to settle obligations, shares          
Discount on debentures payable           928,724
Issuance of warrants attached to debt        
Distributions (297,369) (297,369)
Net income (loss) 4,653,875 147,346 4,801,221
Balances at June 30, 2020 at Jun. 30, 2019 $ 215,591 $ 2,080,000 100,621,830 (20,921,933) 829,945 82,825,433
Balance, shares at Jun. 30, 2019 215,591,103 752,260        
Balances at December 31, 2019 at Dec. 31, 2018 $ 211,013 $ 169,123 87,180,165 (25,575,808) (220,032) 61,764,461
Balance, shares at Dec. 31, 2018 211,013,043 97,136        
Balances at June 30, 2020 at Dec. 31, 2019 $ 228,408 $ 1,168,074 112,245,730 (106,760,527) (553,465) 6,328,220
Balance, shares at Dec. 31, 2019 228,408,024 3,236,857        
Issuance of subscribed shares $ 3,237 $ (1,168,074) 1,164,837
Balance, shares 3,236,857 (3,236,857)        
Stock grants $ 30 $ 5,365 5,335 10,730
Beneficial conversion feature on debentures payable 379,183 379,183
Conversion of debentures payable 35,887 4,981,208 5,017,095
Conversion of common stock to preferred stock $ (4,908) (14,720,092) (14,725,000)
Balance, shares (4,908,333)          
Conversion of promissory note $ 2,525 457,525 460,050
Conversion of promissory notes, shares 2,525,596          
Extinguishment of promissory note $ 1,900 350,100 352,000
Extinguishment of promissory note, shares 1,900,000          
Common stock issued to settle obligations $ 4,400 739,200 743,600
Common stock issued to settle obligations, shares 4,400,000          
Discount on debentures payable 28,021 28,021
Amortization of option grants 556,379 556,379
Issuance of warrants attached to debt 65,931 65,931
Distributions (166,952) (166,952)
Net income (loss) (3,635,481) 156,533 (3,478,948)
Balances at June 30, 2020 at Jun. 30, 2020 $ 271,479 $ 5,365 $ 106,253,357 $ (110,396,008) $ (563,884) $ (4,429,691)
Balance, shares at Jun. 30, 2020 271,479,247 34,171        
Balance, shares 30,307 34,171